95 related articles for article (PubMed ID: 8688152)
1. Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines.
Faure Vigny H; Heddi A; Giraud S; Chautard D; Stepien G
Mol Carcinog; 1996 Jul; 16(3):165-72. PubMed ID: 8688152
[TBL] [Abstract][Full Text] [Related]
2. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria.
Giraud S; Bonod-Bidaud C; Wesolowski-Louvel M; Stepien G
J Mol Biol; 1998 Aug; 281(3):409-18. PubMed ID: 9698557
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
7. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.
Vilà MR; Nicolás A; Morote J; de I; Meseguer A
Cancer; 2000 Jul; 89(1):152-64. PubMed ID: 10897012
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
10. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
11. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells.
Kanayama H; Tanaka K; Aki M; Kagawa S; Miyaji H; Satoh M; Okada F; Sato S; Shimbara N; Ichihara A
Cancer Res; 1991 Dec; 51(24):6677-85. PubMed ID: 1660345
[TBL] [Abstract][Full Text] [Related]
12. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
Tobe SW; Noble-Topham SE; Andrulis IL; Hartwick RW; Skorecki KL; Warner E
Clin Cancer Res; 1995 Dec; 1(12):1611-5. PubMed ID: 9815963
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
17. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation.
Barath P; Luciakova K; Hodny Z; Li R; Nelson BD
Exp Cell Res; 1999 May; 248(2):583-8. PubMed ID: 10222150
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
20. Quantification of OXPHOS gene transcripts during muscle cell differentiation in patients with mitochondrial myopathies.
Bonod-Bidaud C; Giraud S; Mandon G; Mousson B; Stepien G
Exp Cell Res; 1999 Jan; 246(1):91-7. PubMed ID: 9882518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]